Changes in T-cell subsets identify responders to FcR-nonbinding anti-CD3 mAb (teplizumab) in patients with type 1 diabetes
published in: European Journal of Immunology
date of publication: 2015-10-31
language: English
main subject: type-1 diabetes
Cites articles 33
- 2014-11-29
Date
Title
Article - wd:Q36940282